Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgiy Nikonov

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 30, 2021
NB-33, a bioreversible opioid derivative of Nalbuphine, shows enhanced pharmacodynamicsMichael Voronkov, Georgiy Nikonov, Roman Naumov, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Nalbuphine Potentiates Reversal of Fentanyl Overdose by NaloxoneMihai Cernea, Georgiy Nikonov, Janna Ataiants, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Is Fentanyl Rebound an Intrinsic Feature of Naloxone Reversal?Michael Voronkov, Georgiy Nikonov, Melda Uzbil, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Does Kappa Agonism Improve Reversal of 'Tranq-Dope' Overdose? Evidence from a Rodent ModelMichael Voronkov, Mihai Cernea, Cristina Stefanut, et al.
International Journal of Pharmaceutics|December 1, 2021
Modifying naloxone to reverse fentanyl-induced overdoseMichael Voronkov, Georgiy Nikonov, Janna Ataiants, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 30, 2021
NB-33, a bioreversible opioid derivative of Nalbuphine, shows enhanced pharmacodynamicsMichael Voronkov, Georgiy Nikonov, Roman Naumov, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Nalbuphine Potentiates Reversal of Fentanyl Overdose by NaloxoneMihai Cernea, Georgiy Nikonov, Janna Ataiants, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Is Fentanyl Rebound an Intrinsic Feature of Naloxone Reversal?Michael Voronkov, Georgiy Nikonov, Melda Uzbil, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Does Kappa Agonism Improve Reversal of 'Tranq-Dope' Overdose? Evidence from a Rodent ModelMichael Voronkov, Mihai Cernea, Cristina Stefanut, et al.
International Journal of Pharmaceutics|December 1, 2021
Modifying naloxone to reverse fentanyl-induced overdoseMichael Voronkov, Georgiy Nikonov, Janna Ataiants, et al.
Pageof 1